The African Centers for Disease Control and Prevention (Africa CDC) declared a public health emergency due to a significant increase in mpox (formerly known as monkeypox) cases across the continent, with a rise of over 160% reported recently. This declaration coincides with an ongoing outbreak that has brought global attention to the disease, especially as it resurfaces in countries with past incidences of similar viral infections.
Health authorities in Africa are particularly concerned about the increased number of cases, which has escalated to thousands in multiple nations since early 2024, raising alarms about the potential for widespread transmission. The African CDC reports that the illness disproportionately affects vulnerable populations, creating a pressing need for public health interventions, awareness campaigns, and the distribution of vaccines to limit the outbreak.
Countries such as Nigeria and the Democratic Republic of the Congo have noted substantial increases in infections, prompting discussions among health leaders about enhanced preparedness measures. The World Health Organization (WHO) has also been monitoring the situation closely and is evaluating whether to classify the mpox outbreak as a Public Health Emergency of International Concern.
In parallel, regions outside of Africa—including Canada—are witnessing a rise in mpox cases, prompting public health agencies to recommend vaccinations for high-risk populations. The resurgence of mpox, combined with the emergence of mutant strains, has raised fears of a potential global health crisis similar to the previous COVID-19 pandemic.
In summary, the Africa CDC's declaration highlights the urgent need for coordinated responses to manage the mpox outbreak effectively, drawing attention to the interconnected nature of global health security.